Abnormal global longitudinal strain was present in over 40% of asymptomatic childhood cancer survivors, linked to higher anthracycline exposure and metabolic risk factors.
What is the prevalence of subclinical cardiac dysfunction assessed by global longitudinal strain in asymptomatic childhood cancer survivors, and is it associated with treatment exposure and metabolic risk factors?
Over 40% of asymptomatic childhood cancer survivors exhibit subclinical cardiac dysfunction on strain imaging, highlighting the importance of routine echocardiographic surveillance and management of modifiable metabolic risk factors.
Absolute Event Rate: 0% vs 0%
OBJECTIVE: To evaluate subclinical cardiac dysfunction and its association with treatment exposure and metabolic risk factors in a cohort of asymptomatic childhood cancer survivors (CCS). METHODS: In this cross-sectional, observational, single-centre study, pediatric and young adult CCS were evaluated. Eligible participants were diagnosed before 18 years of age and had completed cancer therapy at least two years prior to enrolment. Data on cancer history, treatment exposures, and comorbidities were extracted from electronic medical records. Cardiovascular evaluation included history, physical examination, electrocardiogram, and comprehensive 2D-echocardiography with global longitudinal strain (GLS) analysis. Cumulative anthracycline-equivalent doses (CAE) and radiation exposure to the heart were documented. RESULTS: Out of 456 CCS, anthracycline exposure was noted in 88% [mean (SD) CAE dose: 178.1 (123.2) mg/m CONCLUSION: Abnormal GLS was prevalent in over 40% of asymptomatic CCS. Higher anthracycline exposure and presence of obesity and dyslipidemia were linked with subclinical cardiac dysfunction. These findings underscore the need for routine cardiac surveillance using strain imaging and aggressive management of modifiable risk factors to mitigate long-term cardiovascular morbidity in CCS.
Jain et al. (Wed,) reported a other. Abnormal global longitudinal strain was present in over 40% of asymptomatic childhood cancer survivors, linked to higher anthracycline exposure and metabolic risk factors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: